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BACKGROUND
•  Breastfed infants may be at risk for exposure to a drug or other substance 
present in breastmilk. 
•  Lactating women may become concerned about potential exposures to 
their infant through breastmilk, and may consult a poison center for 
information, or a potential exposure via lactation. 
•  There is a paucity of published descriptions of the patients or substances 
involved in breastmilk exposure or information calls to United States  
poison centers.
METHODS
•  This study analyzed reports to the National Poison Data System (NPDS) 
from 2001 through 2017 for exposure with Scenario of ‘Exposure through 
breastmilk’ (Exposures) or information call for ‘Drug use during 
breastfeeding’ (Info Calls). 
•  Data handling and descriptive statistics for these calls including substances 
involved, effects, and disposition were carried out using SAS JMP 12.0.1.
RESULTS
•  Between 2001–2017, U.S. Poison Centers received 76,416 Info Calls and 
2,319 Exposures related to breastmilk. 
EXPOSURE CALLS:
•  Exposures to substances in breastmilk included children who were  
51% female (n=1,184), 41% male (n=948), and the sex was unknown  
in 8% (n=186).
•  Calls were initiated mostly from the caller’s own residence (76%, 
n=1,758) with a smaller percentage from healthcare facilities  
(15.5%, n=360) and 0.6% from a workplace (n=15). 
•  The majority of exposure calls were managed on site (78%, n=1,802); 
297 were en route to a health care facility (HCF) when poison center was 
called (12.8%); and 169 were referred to a HCF (7.3%). 
•  There were 466 exposures (20.1%) managed at a HCF: 269 were 
evaluated and released (58%); 38 were admitted to ICU (8.2%); 53 were 
admitted to floor (11%); 86 were lost to follow up or left against medical 
advice (18%). 
•  Medical outcomes included: one death (0.04%); eight major effect (0.3%); 
43 moderate effect (1.9%); 170 minor effect (7.3%); 390 no effect (16.8%). 
•  The death was a 4-month-old male with a possible exposure to 
benzodiazepines, opioids, and an SSRI via breastmilk, however, the  
death was judged unrelated to the exposure. 
•  The substances associated with major effects among breastfed infants 
included opioids, benzodiazepines, ethanol, cyclobenzaprine, insulin, and 
amphetamines (See Table 1).
•  Exposure calls were most commonly in reference to antibiotics, antifungals, 
benzodiazepines, opioids, and SSRIs. 
•  Figure 1 shows the substances (by generic code) most commonly reported 
in exposures.
•  1,192 exposures (51.4%) had reported signs/symptoms. The most 
common signs/symptoms were drowsiness, agitation, rash, and vomiting/
diarrhea (Figure 2). 
•  Dilution, irrigation, washing and food/snack were the most common 
interventions (Figure 3). 
•  Figure 4 shows incidence of calls to poison centers regarding potential 
exposures via breastmilk over time. 
INFORMATION CALLS:
•  For comparison, data on Information Calls for those same substances  
are shown (Figure 1). Information calls were most commonly in reference 
to systemic antibiotics, SSRIs, antihistamines, corticosteroids and 
benzodiazepines. 
CONCLUSIONS
•  Substances common to both exposures via breastmilk and information 
calls concerning drug use during breastfeeding included antibiotics, 
benzodiazepines, and SSRIs. 
•  Most cases of severe toxicity included potential exposures via breastmilk to 
benzodiazepines and opioids. 
•  These data should help inform educational outreach and bedside care for 
breastfeeding mothers. 
•  Further study into exposures via breastmilk may help inform an 
understanding of the potential risks of substance exposure to  
breastfed infants. 
Exposures through Breastmilk: An Analysis of Exposure and Information Calls to US Poison Centers, 2001–2017
Gillian A. Beauchamp, MD,1 Robert G. Hendrickson, MD,2 B. Zane Horowitz, MD,2 Daniel A. Spyker, PhD, MD2
1Lehigh Valley Health Network, Department of Emergency and Hospital Medicine, Section of Medical Toxicology/University of South Florida Morsani College of Medicine, Allentown, PA 
2Oregon Health & Science University Department of Emergency Medicine/Oregon, Alaska and Guam Poison Center, Portland, OR
Table 1. Infants with Exposures to 
Substances via Breastmilk 2001-2017 
with Medical Outcome of Major Effect 
or Death 
Figure 1. Generic Codes for NPDS 2001–2017, 
Exposures through Breastmilk: (% of 2,319) 
Info Calls for use During Breastfeeding (% of 76,416)
Figure 2. Clinical Effects as Percent of 2,319 
Exposures via Breastmilk NPDS 2001–2017 Figure 3. Treatment: Percent of 2,319 Exposures 
via Breastmilk NPDS 2001–2017 Figure 4. Incidence of Calls to Poison Centers 
for Infants with Exposures to Substances via 
Breastmilk by Year 2001-2017
